Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Intralesional injections of Citoprot‐P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation
Intralesional injections of Citoprot‐P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation
Intralesional injections of Citoprot‐P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation
International Wound Journal ; 4 ; 326-327
01.12.2007
2 pages
Aufsatz (Zeitschrift)
Elektronische Ressource
Englisch
Risk factors for amputation in diabetic foot ulcers: A retrospective analysis
Wiley | 2024
|Risk factors for amputation in diabetic foot ulcers: A retrospective analysis
Wiley | 2024
|Risk factors for amputation in diabetic foot ulcers: A retrospective analysis
Wiley | 2024
|Risk factors for amputation in diabetic foot ulcers: A retrospective analysis
Wiley | 2024
|